Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Repligen reported $151.4M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Agilent A:US USD 1.33B 4M
Align Technology ALGN:US USD 809.63M 20.78M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Bruker BRKR:US USD 562.6M 14.8M
Catalent CTLT:US USD 1.01B 49M
Charles River Laboratories CRL:US USD 738.08M 197.95M
Danaher DHR:US USD 5.37B 700M
Dentsply International XRAY:US USD 980M 59M
Exact Sciences EXAS:US USD 679.54M 7.66M
General Electric GE:US USD 14.5B 7.3B
Henry Schein HSIC:US USD 2.88B 414M
Illumina ILMN:US USD 1.15B 59M
IQVIA Holdings Inc IQV:US USD 3.18B 179M
Myriad Genetics MYGN:US USD 233.4M 3.4M
NanoString Technologies NSTG:US USD 76.35M 748K
OraSure Technologies OSUR:US USD 130.64M 21M
Pacific Biosciences Of California PACB:US USD 130.15M 15.72M
Patterson Companies PDCO:US USD 1.52B 41.18M
Peregrine Pharmaceuticals PPHM:US USD 35.3M 2.14M
Pfizer PFE:US USD 11.5B 7.63B
Repligen RGEN:US USD 151.4M 13.48M
Thermo Fisher Scientific TMO:US USD 9.15B 442M
Waters WAT:US USD 510.51M 61.72M
West Pharmaceutical Services WST:US USD 561.3M 19.1M